FDA ends Teva Plan B OTC dominance

Share this article:

Plan B is now going generic. NPR reports that the FDA did a 180 on its July 2012 marketing decision that allowed the emergency contraception to be sold over the counter without an age restriction.

The age-free availability came after legal wrangling that brought together the FDA, the Department of Justice, and the United States District Court for the Eastern District of New York.

Pro-limit parties, which included the Department of Justice and the White House, backed off, keeping it out of the Supreme Court. The détente came with a provision in which the FDA granted drugmaker Teva three years of generic protection. NPR reports that the regulator has changed its mind as long as generic labels note that the drug is meant for women 17 or older.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.